FDA cracks down again on health claims, but seems receptive to CBD

Scrutiny of the CBD market appears to be growing at the US Food and Drug Administration (FDA), which this week reprimanded a further 15 companies for selling CBD products as drugs and also updated its advice to consumers on potential dangers ...

Restricted content. Do you want to read more?